Adjuvant chemotherapy after radical liver resection in the treatment of metastases from colorectal carcinoma;Ruolo della chemioterapia adiuvante dopo resezione epatica radicale nel trattamento delle metastasi da carcinoma del colon-retto

Minerva Chirurgica

Volumn 64, Issue 5, 2009, Pages 457-463

  Mammano, E ^a   Pilati, P ^a   Tessari, E ^a   Cosci, M ^a   Mocellin, S ^a   Nitti, D ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Chemotherapy, adjuvant; Colorectal neoplasms; Liver neoplasms, surgery

Indexed keywords

ADJUVANT CHEMOTHERAPY; COLORECTAL TUMOR; HUMAN; LIVER RESECTION; LIVER TUMOR; METASTASIS; PATHOLOGY; REVIEW;

CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS;

EID: 77249089991     PISSN: 00264733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Penna C, Nordlinger B. Colorectal metastasis (liver and lung). Surg Clin North Am 2002;82:1075-90.
2. Hughes KS, Simon R, Songhorabodi S, Adson MA, Ilstrup DM, Fortner JG et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986;100: 278-84.
3. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759-661
4. Scheele J, Altendorf-Hofmann A, Grube T, Hohenberger W, Stangl R, Schmidt K. Resection of colorectal liver metastases. What prognostic factors determine patient selection? Chirurg 2001;72:547-60.
5. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer 1996;77:1254-62.
6. Hohn DC, Stagg RJ, Friedman MA, Hannigan JF Jr, Rayner A, Ignoffo RJ et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 1989;7:1646-54.
7. Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992;10:1112-8.
8. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994;344:1255-60.
9. Lygidakis NJ, Ziras N, Parissis J. Resection versus resection combined with adjuvant pre- and post-operative chemotherapy immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology 1995;42:155-61.
10. Asahara T, Kikkawa M, Okajima M, Ojima Y, Toyota K, Nakahara H et al. Studies of postoperative transarterial infusion chemotherapy for liver metastasis of colorectal carcinoma after hepatectomy. Hepatogastroenterology 1998;45:805-11.
11. Rudroff C, Altendorf-Hoffmann A, Stangl R, Scheele J. Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases. Langenbecks Arch Surg 1999;384: 243-9.
12. Lorenz M, Müller HH, Schramm H, Gassel HJ, Rau HG, Ridwelski K et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 1998;228:756-62.
13. Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy an inter-group study. J Clin Oncol 2002;20:1499-50.
14. Tono T, Hasuike Y, Ohzato H, Takatsuka Y, Kikkawa N. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study. Cancer 2000;88:1549-56.
15. Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341:2039-48.
16. Nelson RL, Freels S. Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver. Cochrane Database Syst Rev 2006;(4):CD003770.
17. Lopez-Ladron A, Salvador J, Bernabe R, Bernardos A, Arriola E, Serrano J et al. Observation versus postoperative chemotherapy after resection of liver metastases in patients with advanced colorectal cancer. Proc Am Soc Clin Oncol 2003 abstr 1497.
18. Langer B, Bleiberg H, Labianca R, Sheperd L, Nitti D, Marsoni S et al. Fluorouracil (FU) plus I-leucovorin (I-LV) versus observation after potentially curative resection of liver or lung metastases from colorectal cancer (CRC): results of the ENG (EORTC/NCIC CTG/GVIO) randomized trial. Proc Am Soc Clin Oncol 2002 abstr 592.
19. Portier G, Elias D, Bouche O, Rougier P, Bosset JF, Saric J et al. Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial. J Clin Oncol 2006;24:4976-82.
20. Mitry E, Fields AL, Bleiberg H, Labianca R, Portier G, Tu D et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 2008;26:4906-11.
21. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist 2008;13:51-64.
22. de Haas RJ, Wicherts DA, Flores E, Azoulay D, Castaing D, Adam R. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery? Ann Surg 2008;248:626-37.
23. O'Neil BH, Goldberg RM. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials. Oncologist 2008;13:1074-83.
24. Oussoultzoglou E, Romain B, Panaro F, Rosso E, Pessaux P, Bachellier P et al. Long-term survival after liver resection for colorectal liver metastases in patients with hepatic pedicle lymph nodes involvement in the era of new chemotherapy regimens. Ann Surg 2009;249:879-86.
25. Kemeny N, Capanu M, D'Angelica M, Jarnagin W, Haviland D, Dematteo R et al. Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Ann Oncol 2009;20: 1236-41.